Evidence map›Paper›PMID 26719689›Full record

ArticleInternational journal of nanomedicine2015

Antioxidant and hepatoprotective role of gold nanoparticles against murine hepatic schistosomiasis.

Mohamed A Dkhil, Amira A Bauomy, Marwa S M Diab, Saleh Al-Quraishy

Open access · goldAbstract read
In one paragraph

Article in International journal of nanomedicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 61 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. NLRP3 inflammasome inhibition decreasesInfection and immunity · 2024
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Nanoparticles as Potent Agents for Treatment ofCurrent therapeutic research, clinical and experimental · 2023
    Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Effect of nanoparticles on the therapeutic efficacy of praziquantel againstJournal of parasitic diseases : official organ of the Indian Society for Parasitology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 2 countries.

Mohamed A DkhilDepartment of Zoology, College of Science, King Saud University, Riyadh, Saudi Arabia ; Department of Zoology and Entomology, Faculty of Science, Helwan University, Cairo, Egypt.
Amira A BauomyDepartment of Zoology and Entomology, Faculty of Science, Helwan University, Cairo, Egypt ; Department of Laboratory Sciences, College of Science & Arts, Qassim University, Buraydah, Saudi Arabia.
Marwa S M DiabMolecular Drug Evaluation Department, National Organization for Drug Control & Research (NODCAR), Giza, Egypt.
Saleh Al-QuraishyDepartment of Zoology and Entomology, Faculty of Science, Helwan University, Cairo, Egypt.
Helwan University · EGKing Saud University · SANational Organization for Drug Control and Research · EGQassim University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent years, gold nanoparticles (AuNPs) have become the focus of much attention in biomedical research, especially in the context of nanomedicine, due to their distinctive physicochemical properties. The current study was planned to assess the effect of three dose levels of AuNPs on the gene expression, histology, and oxidative stress status of Schistosoma mansoni-infected mice liver. Inoculation of mice with 100 μL AuNPs at different doses (0.25, 0.5, and 1 mg/kg mice body weight) twice on day 46 and day 49 postinfection reduced the total worm burden, the egg load in the liver, and the granuloma size. AuNPs also appeared to decrease the activities of malondialdehyde and nitric oxide significantly, and increase the level of glutathione compared to the infected untreated group. Concomitantly, AuNPs ameliorated the inflammatory response by decreasing the mRNA expression of interleukin-1β, interleukin-6, tumor necrosis factor-α, interferon-γ, and inducible nitric oxide synthase. These consistent molecular, histopathological, and biochemical data suggest that AuNPs could ameliorate infection-induced damage in the livers of mice. Our results indicated that AuNPs are effective anti-schistosomal and antioxidant agents. Further confirmation of the role of nanogold as an anti-schistosomal agent, as well as its mechanism of action, requires further studies to be undertaken in the future.

Indexed as

AnimalsAntioxidantsGlutathioneGoldInterferon-gammaInterleukin-1betaInterleukin-6LiverMaleMalondialdehydeMetal NanoparticlesMiceOxidative StressProtective AgentsReal-Time Polymerase Chain ReactionSchistosoma mansoniAntioxidantsGlutathioneGoldIL6 protein, humanInterferon-gammaInterleukin-1betaInterleukin-6MalondialdehydeProtective AgentsTumor Necrosis Factor-alphagene expressionshistopathologylivermicenanogoldoxidative stressSchistosoma mansoni

Identifiers

PMID26719689
PMCPMC4687720
OpenAlexW2207824922

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.